Study Evaluating Pantoprazole in Children With GERD
Completed
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 3
2005-08-01
The purpose of this study is to characterize the PK profile, safety and tolerability of
single and multiple doses of pantoprazole in children aged 1 through 11 years with
endoscopically proven GERD.
Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD
Completed
Nycomed
Phase 3
2005-11-01
The purpose of this study is to characterize the pharmacokinetic (PK) and pharmacodynamic
(PD) profiles to determine the safety and tolerability of single and multiple doses of
pantoprazole in infants aged 1 through 11 months.
Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD
Completed
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 3
2005-11-01
The purpose of this study is to characterize the pharmacokinetic (PK) and pharmacodynamic
(PD) profiles to determine the safety and tolerability of single and multiple doses of
pantoprazole in infants aged 1 through 11 months.
Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD)
Completed
Nycomed
Phase 3
2006-05-01
To evaluate the clinical outcomes of treatment with oral pantoprazole in children 1 through 5
years of age with endoscopically proven symptomatic GERD.
Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD)
Completed
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 3
2006-05-01
To evaluate the clinical outcomes of treatment with oral pantoprazole in children 1 through 5
years of age with endoscopically proven symptomatic GERD.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
